Filing Flows › Collegium Pharmaceutical (COLL) › Net income
Collegium Pharmaceutical (COLL) net income by quarter
Collegium Pharmaceutical's net income was $21.8M in Q3 2026 (third quarter 2026), +50% from Q1 2026. Over the last 6 quarters it ranged from $2.4M (Q1 2025) to $31.5M (Q3 2025).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $21.8M | +50% | -31% |
| Q1 2026 | $14.5M | -15% | +500% |
| Q4 2025 | $17.0M | -46% | — |
| Q3 2025 | $31.5M | +163% | — |
| Q2 2025 | $12.0M | +396% | — |
| Q1 2025 | $2.4M | — | — |
Q3 2026 at a glance
Collegium Pharmaceutical, Q3 2026: revenue $216M (+3% year over year), operating margin 13.3%, net earnings $21.8M, operating cash flow $86.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Collegium Pharmaceutical's net income?
Collegium Pharmaceutical's net income was $21.8M in Q3 2026 (third quarter 2026), +50% from Q1 2026.
How has Collegium Pharmaceutical's net income changed?
Over the last 6 quarters it ranged from $2.4M (Q1 2025) to $31.5M (Q3 2025).
Q3 2026 results → · How Collegium Pharmaceutical makes money →